Codexis partners with siRNA drug innovator for enzymatic oligonucleotide synthesis
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
The economist who coined the phrase ‘Magnificent 7’ says the very thing that made them extraordinary is under threat
"Let's not forget that the Mag7, the hyperscalers, whatever you want to call them, part of the reason to say they're magnificent is because they made magnificent amounts of cash and didn't spend any…
Patagonia Gold Announces Positive Preliminary Economic Assessment for the Calcatreu Gold-Silver Project
PEA outlines US$334 million after-tax NPV (10%), 282% IRR and a 16-year mine life, with additional exploration potential across the broader Calcatreu District VANCOUVER, British Columbia, Sept.
Citi Recommends Buying China’s 30-Year Bonds on Weak Growth View
Citigroup Inc. is advising investors to buy 30-year Chinese government bonds as it expects lingering weakness in the economy and tapering supply of longer-term debt to boost demand for the paper.
Troilus Receives US$850 Million Credit-Approved Debt Commitment Letter for the Troilus Gold-Copper Project
MONTREAL, Sept. 28, 2026 (GLOBE NEWSWIRE) — Troilus Mining Corp. (“Troilus” or the “Company”) (TSX: TLG; OTCQX: CHXMF; FSE: CM5) is pleased to announce that it has received a credit-approved…
Prediction: Tesla Stock Will Plunge to $100 if the S&P 500 Enters a Bear Market
Tesla's sky-high valuation sets the stage for a significant potential correction.